Published in Am J Cardiol on October 01, 1993
New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex Heart Inst J (1995) 0.80
Coronary intravascular ultrasound in 2 children after cardiac transplantation. Tex Heart Inst J (1994) 0.76
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Kidney transplantation under FK 506. JAMA (1990) 7.45
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Fluorescent-antibody test for cytomegalovirus macroglobulin. N Engl J Med (1968) 3.51
Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48
Designing Endocrine Disruption Out of the Next Generation of Chemicals. Green Chem (2013) 2.47
A self-sustaining ultrahigh-frequency nanoelectromechanical oscillator. Nat Nanotechnol (2008) 2.43
Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39
The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22
A comparison of fluorescent Ca2+ indicator properties and their use in measuring elementary and global Ca2+ signals. Cell Calcium (2000) 2.21
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15
Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10
Calcium signalling--an overview. Semin Cell Dev Biol (2001) 2.06
Reduction in radiation exposure during coronary angiography. Cathet Cardiovasc Diagn (1990) 2.03
Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol (1997) 1.98
Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96
Interparietal bones in Nigerian skulls. J Anat (1986) 1.95
BCL-6 expression during B-cell activation. Blood (1996) 1.95
Sensitivity of meningococci to sodium sulphadiazine and six antibiotics. J Med Microbiol (1970) 1.83
Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75
Investigating the thyroid nodule. BMJ (2009) 1.73
Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology (1995) 1.73
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection (2013) 1.59
Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc (1990) 1.56
Vertebral artery stenting. Catheter Cardiovasc Interv (2001) 1.55
Ambiguous coronary angiography: clinical utility of intravascular ultrasound. Cathet Cardiovasc Diagn (1992) 1.54
Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53
Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52
Polymerase chain reaction vs. conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol (2001) 1.51
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
A new balloon-expandable tantalum coil stent: angiographic patency and histologic findings in an atherogenic swine model. J Am Coll Cardiol (1992) 1.48
Myocardial ischemia caused by postoperative malfunction of a patent internal mammary coronary arterial graft. J Vasc Surg (1990) 1.48
Bacteriology of neonatal septicaemia in a tertiary care hospital of northern India. Indian J Med Microbiol (2007) 1.48
Converted laparoscopic colorectal surgery. Surg Endosc (2001) 1.48
Percutaneous bailout therapy of a perforated vein graft using a stent-autologous vein patch. Cathet Cardiovasc Diagn (1996) 1.47
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Cathet Cardiovasc Diagn (1998) 1.45
Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis (1992) 1.45
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes. Chest (1997) 1.45
Coronary artery fistula related to dilatation of totally occluded vessel. Clin Cardiol (1993) 1.44
Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv (2008) 1.43
Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43
Glutathione is required for intestinal function. Proc Natl Acad Sci U S A (1990) 1.43
Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A (1991) 1.43
Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) (2002) 1.42
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis (2002) 1.40
Valvular regurgitation and right-sided cardiac pressures in heart transplant recipients by complete Doppler and color flow evaluation. Chest (1993) 1.40
Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40
Attenuation of waiting time mortality with heterotopic heart transplantation. Ann Thorac Surg (1992) 1.39
Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res (2006) 1.39
Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39
Gallbladder carcinoma: experience of 116 cases. Trop Gastroenterol (2000) 1.39
Intravascular ultrasound-guided transluminal extraction atherectomy for restenosis after Gianturco-Roubin coronary stent implantation. Cathet Cardiovasc Diagn (1996) 1.39
Induction of ventricular tachycardia in patients with left ventricular aneurysms and no history of arrhythmia. Am J Cardiol (1988) 1.39
Initial results of peripheral vascular angioplasty performed by experienced interventional cardiologists. Am J Cardiol (1992) 1.39
Methotrexate for rheumatoid arthritis. J Assoc Physicians India (1994) 1.39
Recanalization of arterial occlusions with a lensed fiber and a holmium:YAG laser. Lasers Surg Med (1991) 1.39
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation (1994) 1.39
High-speed rotational ablation (Rotablator) for unfavorable lesions in peripheral arteries. Cathet Cardiovasc Diagn (1993) 1.38
Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38
Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A (1989) 1.37
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Neurologic complications of FK 506. Transplant Proc (1991) 1.34
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci U S A (1988) 1.31
Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol (1996) 1.30
Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30
De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30